Viewing nowValsartan 40 mg
Valsartan 40mg
Tablet · Prescription medication
HK inno.N Co., Ltd.

MFDS item code 201201166 · Approved 2012.02.24 · Insurance code 640006350
Treatment of essential hypertension; reduction of the risk of death after myocardial infarction; improvement of heart failure
This medication is used to reduce the risk of death in patients with essential hypertension, heart failure (especially NYHA class II to IV heart failure patients who cannot use ACE inhibitors), and left ventricular dysfunction after myocardial infarction. Therefore, it is effective in controlling blood pressure, supporting heart function, and preventing complications after myocardial infarction.
* 40, 80, 160 mg 1. Essential hypertension Take with water during a meal or between meals. It is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. 1) Adults: The recommended dose is 80 mg of valsartan orally once daily, regardless of sex or race. The blood pressure-lowering effect develops gradually within 2 weeks and reaches its maximum after 4 weeks. For patients whose blood pressure is not adequately controlled, the dose may be increased to 160 mg daily or a diuretic may be coadministered. If further blood pressure reduction is needed, the dose may be increased to a maximum of 320 mg daily. 2) Older adults (75 years and older): Start treatment with 40 mg of this medicine once daily. 3) Patients with renal impairment: (1) Creatinine clearance 20 ∼ 50 mL/min: No dose adjustment is necessary. (2) Creatinine clearance 10 ∼ 20 mL/min: Start treatment with 40 mg of this medicine once daily. (3) Creatinine clearance below 10 mL/min and patients on dialysis: Do not administer this medicine. 4) Patients with volume depletion: In patients with volume depletion (e.g., patients taking high-dose diuretics whose dose cannot be reduced), start treatment with 40 mg of this medicine once daily. 5) Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, start treatment with 40 mg of this medicine once daily, and do not exceed 80 mg daily. Do not administer this medicine to patients with severe hepatic impairment, cirrhosis, or cholestasis. 2. Heart failure Adults: The recommended starting dose is 40 mg of this medicine orally twice daily, which may be increased to 80 mg or 160 mg per dose. When coadministered with a diuretic, consider reducing the diuretic dose. The maximum daily dose is 320 mg, given in divided doses. Triple combination therapy with this medicine, an ACE inhibitor, and a beta-blocker is not recommended. 3. Reduction of risk of death after myocardial infarction Adults: Treatment may be initiated within 12 hours of the onset of myocardial infarction. The recommended starting dose is 20 mg of this medicine twice daily, followed over several weeks by dose increases, as tolerated by the patient, to 40 mg, 80 mg, and 160 mg per dose twice daily. Consider dose reduction if symptoms of hypotension or renal failure occur. This medicine may also be administered to patients receiving other treatments after myocardial infarction (e.g., thrombolytics, acetylsalicylic acid, beta-blockers, and statins). However, coadministration with an ACE inhibitor is not recommended. 4. Patients with renal impairment: No dose adjustment is necessary for a creatinine clearance of 10 mL/min or more; however, do not administer this medicine to patients with a creatinine clearance below 10 mL/min or patients on dialysis, as there is no experience with its use in these patients. 5. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, it is preferable that the daily dose of this medicine not exceed 80 mg. If a dose of 80 mg or more daily is administered, consider whether the benefits of treatment outweigh the risks when increasing the dose. Do not administer this medicine to patients with severe hepatic impairment, cirrhosis, or cholestasis.
The safety and efficacy of this medicine have not been established in children and adolescents under 18 years of age. The safety and efficacy of this medicine have not been established in children and adolescents under 18 years of age.
This medication can cause severe harm to the fetus when taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately if pregnancy is confirmed. Pregnant or nursing women, and individuals allergic to this medication or its components should not take it. Patients with severely impaired liver or kidney function and those with a history of certain vascular edema should also avoid this medication. Elderly patients, those with high potassium levels, or mildly impaired liver function should take this medication with caution and may require dose adjustments. This medication can have a strong blood pressure-lowering effect, so caution is needed as dizziness or fainting may occur when starting treatment. When taken with other antihypertensive medications or diuretics, there is a risk of blood pressure falling too low, so it should only be taken under medical supervision. During treatment with this medication, it's important to regularly monitor kidney function and potassium levels through blood tests. If dizziness or symptoms of orthostatic hypotension occur, it is safe to avoid driving or operating machinery. Taking potassium-sparing diuretics or potassium supplements may cause dangerously high potassium levels in the blood, so caution is advised. In case of overdose, severe hypotension or decreased consciousness may occur, and immediate medical attention is necessary. Safety in children or adolescents under 18 has not been established; therefore, use is discouraged. This medication should be kept out of reach of children and should not be transferred to other containers.
headache
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air and moisture from entering, and kept in a cool place below 30 degrees Celsius to maintain its efficacy.
Yellow oval film-coated tablet with a score line
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowValsartan 40mg
Tablet · Prescription medication
HK inno.N Co., Ltd.

Valsartan 80mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.

Valsartan 160mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.

Valsartan 40mg
Tablet · Prescription medication
Samsung Novartis Co., Ltd.
Valsartan
Prescription medication
Korea Sandos Co., Ltd.
Valsartan
Prescription medication
Korea Sandos Co., Ltd.

Valsartan
Prescription medication
Korea Sandos Co., Ltd.

Valsartan 320mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.